To obtain authorization to bring a medicinal product on the market, 200,000 pages of text need to be submitted. The upcoming effectuation of the IDMP directive (EU) forces pharma companies to submit datasets instead. This has enormous impact. The challenges that this poses are manifold.
Most pharmaceutical companies lack horizontal process integrations; each business silo manages a subset of information around development and product life cycle. During the life span of a product the same characteristics are exchanged by various disciplines.
Residential and office buildings have the largest share in energy consumption, followed by transport and industry. At the same time, many buildings do not leverage all feasible opportunities to increase their energy efficiency.